Elanco Animal Health Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $6.03B | $7.51B | $638.0M |
| FY2022 | $5.45B | $7.29B | $345.0M |
| FY2023 | $5.74B | $6.22B | $352.0M |
| FY2024 | $4.28B | $6.10B | $468.0M |
| FY2025 | $3.76B | $6.55B | $545.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $6.03B | $7.51B | $638.0M |
| FY2022 | $5.45B | $7.29B | $345.0M |
| FY2023 | $5.74B | $6.22B | $352.0M |
| FY2024 | $4.28B | $6.10B | $468.0M |
| FY2025 | $3.76B | $6.55B | $545.0M |